 Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 8 | 3 | 11 | | 1997 | 3 | 4 | 7 | | 1998 | 8 | 2 | 10 | | 1999 | 8 | 1 | 9 | | 2000 | 9 | 2 | 11 | | 2001 | 3 | 5 | 8 | | 2002 | 9 | 1 | 10 | | 2003 | 19 | 2 | 21 | | 2004 | 13 | 4 | 17 | | 2005 | 17 | 10 | 27 | | 2006 | 27 | 3 | 30 | | 2007 | 36 | 8 | 44 | | 2008 | 28 | 6 | 34 | | 2009 | 47 | 4 | 51 | | 2010 | 42 | 11 | 53 | | 2011 | 40 | 13 | 53 | | 2012 | 50 | 13 | 63 | | 2013 | 53 | 8 | 61 | | 2014 | 59 | 15 | 74 | | 2015 | 70 | 10 | 80 | | 2016 | 57 | 12 | 69 | | 2017 | 66 | 18 | 84 | | 2018 | 87 | 16 | 103 | | 2019 | 77 | 12 | 89 | | 2020 | 101 | 10 | 111 | | 2021 | 111 | 8 | 119 | | 2022 | 116 | 4 | 120 | | 2023 | 125 | 3 | 128 | | 2024 | 81 | 10 | 91 | | 2025 | 84 | 5 | 89 | | 2026 | 57 | 4 | 61 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Oser TK, Martens T, Ruedy KJ, Bergford S, Calhoun P, Chang KL, Kramer ES, Klug BA, Anderson RL, Cook BR, Pickering D, Ortega M, Peterson B, Davidson L, Schmid R, Desai ND, Burkett E, Haynes JL, Herman A, Topiwala SM, Bailey R, Oser SM, Cadet NN, Johnson ML, Elkind-Hirsch KE, Beck SE, Castle JR, Beck RW. Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 Diabetes. N Engl J Med. 2026 Oct 29; 395(17):1717-1727.
-
Khunti K, Funnell MP, Highton PJ, Ardavani A, Butler J, Campbell J, Davies MJ, Evley R, Florez JC, Gaglia J, Kulkarni RN, Musi N, Perreault L, Reeve BB, Rosas SE, Routen A, Younossi Z, El Sayed N. Disease modification outcomes in type 2 diabetes: a modified Delphi. Lancet Diabetes Endocrinol. 2026 Nov; 14(11):970-978.
-
Bellido V, le Roux CW, Ekinci EI, Bjornstad P, Frias JP, Giblin K, Eyde S, Park SY, Ferro J, Johnson C, Taylor A. Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial. Lancet. 2026 Oct 10; 408(10563):1455-1472.
-
Kasaie P, Zhao Y, Humes E, Gerace L, Reid K, Lesko CR, Kurgansky KE, Koethe JR, Rebeiro PF, Bourgi K, Erlandson KM, Gebo K, Althoff KN. Impact of an early body mass index maintenance intervention at ART initiation on diabetes risk: Insights from a computer simulation study. Ann Epidemiol. 2026 Nov; 123:110292.
-
Gutierrez-Colina AM, Neiser A, Aichele S, Velasco P, B Goldschmidt A, Lavender JM, Dailey R, Sanchez N, Kelsey MM, Shomaker LB. Evaluating temporal associations between executive functioning, stress and physical activity among adolescents at risk for type 2 diabetes: protocol for an ecological momentary assessment study. BMJ Open. 2026 08 28; 16(8):e116178.
-
Salive ME, Tjaden AH, Ames JR, Crandall JP, Dabelea D, Hazuda HP, Heckman-Stoddard BM, Huckfeldt PJ, Kuo S, Strotmeyer ES, Temprosa M, Venditti EM. Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes. JAMA. 2026 08 18; 336(7):577-586.
-
Oh S, Mitchell CM, White K, Lu M, Hu X, Trost J, Charleston JB, Wu B, Schlechter H, Thomas L, Sabie A, Chung JT, Rebholz CM, Juraschek SP, Mueller NT, Wang NY, Selvin E, Maruthur NM, Miller ER, Yeh HC, Appel LJ, Pilla SJ. Rationale, design, and methods of the dietary approaches to stop hypertension for diabetes (DASH4D) controlled feeding trial. Contemp Clin Trials. 2026 Oct; 169:108436.
-
Valdez Y, Segev N, Parimi N, Vegesna M, Brown EA, Samuels S, Van Name M, Shah AS, Wolf RM. Real-world effectiveness of tirzepatide among youth with type 2 diabetes and/or obesity: a multicenter analysis. J Pediatr Endocrinol Metab. 2026 Oct 26; 39(10):1007-1016.
-
Wang Y, Sargent JL, Mathieu C, Vazquez-Arreola E, Perreault L, Loos RJF, Lim LL, Sandforth L, Hanson RL, Kullmann S, Sbierski-Kind J, Brucker SY, Hrabé de Angelis M, Theiss F, Icks A, Mohebbi D, Stefan N, Mohan V, Wang T, Preissl H, Bergman M, Tuomilehto J, Hivert MF, Franks PW, Birkenfeld AL. Type 2 diabetes prevention across the life course. Nat Med. 2026 Aug; 32(8):2757-2773.
-
Pistenmaa CL, Doherty L, Hermann EA, Brown AL, Dabelea D, Holguin F, Watson K, Knowler WC, Temprosa M, Barr RG. Lung function after randomization to metformin, lifestyle intervention or placebo in the Diabetes Prevention Program Outcomes Study (DPPOS). Respir Med. 2026 Oct; 262:109077.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|